Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01099345 · ClinicalTrials.gov registry record
A Pilot Trial in a Sleep Laboratory Setting to Observe Night Time Bladder Function of Subjects With Overactive Bladder (OAB)
A clinical trial, sponsored by Astellas Pharma.
- Terminated
- Registry status
- 15
- Enrollment target
NCT01099345 is a clinical trial that was terminated before completion, run by Astellas Pharma. The registered enrollment target is 15 participants.
The verdict
NCT01099345 was terminated before completion, sponsored by Astellas Pharma.
- TERMINATED
- Registry status
- 15 participants
- Enrollment target
Study Summary
This is an observational, pilot, non-treatment study to evaluate and develop clinical variables for distinguishing female OAB subjects that have detrusor overactivity positive (DO+) nocturia from female OAB subjects that have detrusor overactivity negative (DO-) nocturia utilizing a sleep laboratory setting.
Interventions
- PROCEDURE cystometry (CMG)
- PROCEDURE polysomnography (PSG)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2010-07 |
| Est. Completion | 2012-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01099345
The ClinicalTrials.gov registry entry for NCT01099345 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Astellas Pharma, which has 165 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which cystometry (CMG) is the first listed.
NCT01099345 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01099345 about?
NCT01099345 is a clinical study titled "A Pilot Trial in a Sleep Laboratory Setting to Observe Night Time Bladder Function of Subjects With Overactive Bladder (OAB)". This is an observational, pilot, non-treatment study to evaluate and develop clinical variables for distinguishing female OAB subjects that have detrusor overactivity positive (DO+) nocturia from female OAB subjects that have detrusor overactivity negative (DO-) nocturia utilizing a sleep laboratory...
What is the current status of trial NCT01099345?
This trial is currently terminated. The enrollment target is 15 participants. The study started on 2010-07. Estimated completion is 2012-05.
What interventions are being tested in trial NCT01099345?
The interventions under investigation include: cystometry (CMG) (PROCEDURE), polysomnography (PSG) (PROCEDURE).
Who is sponsoring clinical trial NCT01099345?
This trial is sponsored by Astellas Pharma, which has 165 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.